Trial Profile
A Study to Evaluate the Vaccine Effectiveness of PCV13 for Invasive Pneumococcal Disease with 3 + 1 Vaccination Schedule
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2016
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- 07 Mar 2016 New trial record
- 23 Feb 2016 Results published in the Vaccine